Opendata, web and dolomites

BioMensio SIGNED

BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BioMensio project word cloud

Explore the words cloud of the BioMensio project. It provides you a very rough idea of what is the project "BioMensio" about.

uncertain    performance    variety    injuries    patented    helps    war    fuelled    heavy    preventative    provides    saliva    found    rapid    accurate    mechanism    drugged    norms    alcohol    accuracy    virtually    workplace    designed    globally    patient    simultaneously    bulkiness    exceeds    paramedics    off    sized    siemens    police    traffic    spin    mishandling    efficient    proof    deploying    coming    inability    drive    million    centre    deaths    drug    first    drugs    illicit    fatalities    people    driving    platform    company    fatal    government    intoxication    levels    stringent    finland    biomensio    person    mass    tools    drivers    reduce    billion    legalisation    ready    accelerator    bio    machinery    instrumentation    influence    suited    understand    sensing    administrate    solutions    vtt    employers    hampered    device    accidents    detect    caused    backed    deployment    market    minutes    prevent    palm    worldwide    surpassed    narcotics    stage   

Project "BioMensio" data sheet

The following table provides information about the project.

Coordinator
BIOMENSIO OY 

Organization address
address: HERMIANKATU 6-8 H
city: TAMPERE
postcode: 33720
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 3˙560˙030 €
 EC max contribution 2˙492˙021 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMENSIO OY FI (TAMPERE) coordinator 2˙492˙021.00

Map

 Project objective

In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxication testing is an efficient mechanism that helps to avoid drug related fatalities, such as traffic accidents or heavy machinery mishandling. However, the current testing solutions are not suited for wide scale deployment and thus cannot make a meaningful impact in the war against drugs. They are hampered by the bulkiness and high cost of instrumentation, uncertain levels of accuracy, and inability to detect the growing variety of drugs.

BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva, designed specifically for the police to detect drugged drivers, paramedics to better understand patient condition, and employers to prevent workplace injuries. Our patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes. This by far exceeds the performance of any other current or up-and-coming technology.

BioMensio is a spin-off company from Siemens Technology Accelerator and VTT Technical Research Centre of Finland, and has been backed with €3.5 million early stage funding. We are now beyond the proof-of-concept phase and are ready to scale our technology. We target the globally growing €1 billion saliva-based rapid drug testing market, which is fuelled by increasingly stringent government norms and workplace drug testing legalisation worldwide. As the key to reduce drug related fatalities and injuries is widely deploying and applying preventative tools, the main goal of our project is bring our patented bio-sensing platform to the mass market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOMENSIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOMENSIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More  

IRMELI (2019)

AI-BASED BROKERING TECHNOLOGY PLATFORM TO FIND THE PERFECT MATCH BETWEEN THE CUSTOMER AND BANK

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More